MetS is well recognized as an aggregate of cardio-metabolic risk factors subsequent cardiovascular disease and type 2 diabetes mellitus [23,24], and the association of PEDF with MetS and its components has been verified in previous studies [12-14]. This evidence concerns the gene SERPINF1 and cardiovascular disorder.